Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:40 pm Purchase | 2021-12-31 | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 1,572,823 5.300% | 135,247 (+9.41%) | Filing History |
| 2022-02-14 4:40 pm Sale | 2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Point72 Asset Management, L.P. | 228,922 0.300% | -4,915,715 (-95.55%) | Filing History |
| 2022-02-14 4:39 pm Sale | 2021-12-31 | 13G | BELLUS Health Inc. BLU | Point72 Asset Management, L.P. | 56,430 0.100% | -6,183,686 (-99.10%) | Filing History |
| 2022-02-14 4:39 pm Purchase | 2021-12-31 | 13G | TRICIDA INC TCDAQ | Point72 Asset Management, L.P. | 3,284,903 5.900% | 759,365 (+30.07%) | Filing History |
| 2022-02-14 4:38 pm Purchase | 2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | Point72 Asset Management, L.P. | 54,440 5.800% | 4,432 (+8.86%) | Filing History |
| 2022-02-14 4:38 pm Sale | 2021-12-31 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 271,229 1.000% | -1,106,713 (-80.32%) | Filing History |
| 2022-02-14 4:37 pm Purchase | 2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Point72 Asset Management, L.P. | 3,007,138 5.800% | 365,885 (+13.85%) | Filing History |
| 2022-02-14 4:36 pm Sale | 2021-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Point72 Asset Management, L.P. | 163,103 5.500% | -5,608 (-3.32%) | Filing History |
| 2022-02-14 4:35 pm Unchanged | 2021-12-31 | 13G | Blue Owl Capital Inc. OWL | Point72 Asset Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:35 pm Sale | 2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | Point72 Asset Management, L.P. | 1,982,561 5.100% | -665,463 (-25.13%) | Filing History |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | Allena Pharmaceuticals, Inc. ALNAQ | Point72 Asset Management, L.P. | 0 0.000% | -4,000,000 (Position Closed) | Filing History |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 2,420,309 5.100% | -1,908,721 (-44.09%) | Filing History |
| 2022-02-14 4:34 pm Purchase | 2021-12-31 | 13G | Affimed N.V. AFMD | Point72 Asset Management, L.P. | 1,185,559 9.900% | 604,098 (+103.89%) | Filing History |
| 2022-02-14 4:33 pm Sale | 2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS | Point72 Asset Management, L.P. | 241,158 1.600% | -321,544 (-57.14%) | Filing History |
| 2022-02-14 4:33 pm Purchase | 2021-12-31 | 13G | Acorda Therapeutics, Inc. ACOR | Point72 Asset Management, L.P. | 23,214 4.100% | 23,214 (New Position) | Filing History |
| 2022-02-14 4:32 pm Purchase | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Point72 Asset Management, L.P. | 472,864 2.200% | 46,702 (+10.96%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | Golar LNG Limited GLNG | Point72 Asset Management, L.P. | 4,406,367 4.100% | -1,174,969 (-21.05%) | Filing History |
| 2022-02-14 4:31 pm Unchanged | 2021-12-31 | 13G | Bakkt Holdings, Inc. BKKT | Point72 Asset Management, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:31 pm Sale | 2021-12-31 | 13G | Forte Biosciences, Inc. FBRX | Point72 Asset Management, L.P. | 44 0.100% | -27,798 (-99.84%) | Filing History |
| 2022-02-14 4:29 pm Purchase | 2021-12-31 | 13G | Avalo Therapeutics, Inc. AVTX | Point72 Asset Management, L.P. | 2,088 5.400% | 1 (+0.05%) | Filing History |